Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

Baylor Scott and White Health (BSWH)

Status: Completed

Conditions: Heart Failure; Liver Disease

Study type: Observational

Funder types: Other

Identifiers

NCT02070315

012-011

Details and patient eligibility

About

Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.

Full description

To obtain a quantitative evaluation of the progression of liver disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine.

To compare the glomerular filtration rate and the quantitative evaluation of the progression of renal disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine in post-liver transplantation patients.

Enrollment: 1,247 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Males and Females over the age of 18
• Patients of Liver Consultant's of Texas Dallas office, with chronic liver disease or liver transplant patient seen in Liver Transplant Clinic
• Patients diagnosed with heart failure

Exclusion criteria

- Any person unable to provide an informed consent